What a moment for the world — and for science. On Wednesday, the Pfizer/BioNTech vaccine was approved by the UK medicines regulator, making it the first coronavirus vaccine to be approved for mass use in any country after large-scale clinical trials. The vaccine is also one of the most effective, protecting 95 per cent of recipients from disease. There is light on the horizon amid the pandemic’s winter gloom.
对全世界——还有科学来说，这是一个多么激动人心的时刻。周三，辉瑞(Pfizer)和BioNTech联合研制的新冠疫苗获得了英国药品监管机构的批准，成为首款在大规模临床试验后在一个国家获准向大众提供的新冠疫苗。该疫苗也是最有效的疫苗之一，可以保护95%的接种者。在这个大流行肆虐的冬季，阴霾的天空终于出现了曙光。
您已阅读11%（569字），剩余89%（4603字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。